WORLD KIDNEY DAY |
W.G. Cousier, M.K. Riella
World Kidney Day 2011: protecting your kidneys, protect your heart
|
4-7 |
HOTLINE TOPIC |
N.V. Tchebotareva, I.N. Bobckova, L.V. Kozlovskaya, O.A. Li
Dysfunction of renal self-defence mechanisms in chronic glomerulonephritis
|
8-14 |
N.L. Kozlovskaya
Low molecular weight heparins in nephrologists practice
|
15-22 |
STATE-OF-ART |
M.S. Ignatova
Ciliopathies: current concepts
|
23-29 |
ORIGINAL PAPERS |
M.M. Severova, E.A. Saginova, M.G. Gallyamov, N.V. Ermakov, A.V. Rodina, M.V. Severov, V.V. Fomin, N.A. Moukhin
Association of leptinemia and adiponectinemia with chronic kidney disease in patients with metabolic syndrome and non-alcoholic fatty liver disease
|
30-34 |
I.L. Gracheva, I.A. Kazakova
Modern therapy of chronic pyelonepritis in day patient facility
|
35-38 |
M.M. Batiushin, E.S. Levitskaya, V.P. Terenti’ev, A.A. Diugikov, A.V. Poddubny
Influence of cardiovascular and renal risk factors on prognosis of coronary heart disease patients, undergone myocardial revascularization
|
39-42 |
О.V. Rtyscheva, O.F. Kalev, V. Yu. Akhmatov
Сauses of death in patients receiving program heamodalysis
|
43-45 |
P.A. Vorobev, L.J. Bezmelnitsyna
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 1. Epidemiology and use of erythropoietin medications
|
46-51 |
SOCIAL ASPECTS OF NEPROLOGY |
G.P. Arutiunov, L.G. Oganesova
Renal tubulointerstium and it’s involvement in arterial hypertension
|
52-57 |
L. Yu. Milovanova, Yu.S. Milovanov, L.V. Kozlovskaya
Disturbances of calcium-phosphate metabolism disturbances in chronic kidney disease stage III–V
|
58-68 |
V.V. Fomin
Isolated systolic hypertension: global risk factor
|
69-74 |
R.Kh. Galeev, D.D. Khamitov
The current state of problem of kidney tumors and analysis of rational approaches to medical interventions
|
75-77 |
CASE REPORTS |
E.V. Voloshinova, O.S. Lobanova, N.M. Nikitin
Systemic amyloidosis in patient with gout
|
78 |